doi: 10.1097/00007611-198505000-00002.
Neoplasia in immunosuppressed renal transplant patients: a 20-year experience
- PMID: 3887576
- DOI: 10.1097/00007611-198505000-00002
Item in Clipboard
Neoplasia in immunosuppressed renal transplant patients: a 20-year experience
South Med J.
1985 May.
Abstract
This review examines a 20-year experience in renal transplantation at our center to determine the effects of immunosuppression on the subsequent development of malignancies. Twenty patients had 21 malignancies from primary sites other than skin, yielding an incidence of 2.5%. There were 0.65 malignancies for each 100 cumulative patient years of immunosuppression. Suppression of the host immune response is associated with an increased incidence of malignancies.
Similar articles
-
Immunosuppressive drugs used in clinical renal transplantation.Urology. 1977 Jun;9(6 Suppl):52-60. Urology. 1977. PMID: 70101 No abstract available.
-
Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.Transplant Proc. 1993 Jun;25(3):2302. Transplant Proc. 1993. PMID: 8516907 Clinical Trial. No abstract available.
-
Malignancy after immunosuppressive therapy.Boll Ist Sieroter Milan. 1977 Mar 31;56(2):197. Boll Ist Sieroter Milan. 1977. PMID: 326275 No abstract available.
-
Immunosuppressive therapy in renal transplantation.Surg Clin North Am. 1971 Oct;51(5):1191-204. doi: 10.1016/s0039-6109(16)39543-3. Surg Clin North Am. 1971. PMID: 4106550 Review. No abstract available.
-
Antirejection drugs and procedures.Am J Surg. 1973 Nov;126(5):678-82. doi: 10.1016/s0002-9610(73)80021-2. Am J Surg. 1973. PMID: 4129988 Review. No abstract available.
Cited by
-
De novo malignancy after paediatric renal replacement therapy.Arch Dis Child. 2001 Dec;85(6):478-83. doi: 10.1136/adc.85.6.478. Arch Dis Child. 2001. PMID: 11719332 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical